GlassScriptPhysician profile
Adham Abdelfattah
NPI 1073833026
$52,023.74
in general payments reported to CMS, 2019-2025
36 companies · $13K in 2025
The $13K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $5,991 · 2021: $4,084 · 2022: $1,578 · 2023: $13K · 2024: $4,037 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Travel and Lodging: $7,474 · Food and Beverage: $6,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,250.00 |
| Travel and Lodging | $7,473.72 |
| Food and Beverage | $6,114.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $34,247.84 | 2019-2025 | Djo Surgical |
| Zimmer Biomet Holdings, INC. | $3,638.95 | 2019-2025 | Comprehensive Shoulder System, Identity |
| Corentec America INC | $2,792.10 | 2024-2025 | |
| Alliance Partners LLC | $2,322.52 | 2019-2020 | |
| Medacta USA, INC. | $1,994.26 | 2022-2024 | |
| Stryker Corporation | $1,855.92 | 2019-2025 | Mako, T2 Alpha, Blueprint Patient Specific Instrumentation |
| Depuy Synthes Sales INC. | $840.97 | 2020-2024 | Inhance, Dynacord, Bristow Latarjet |
| Catalyst Orthoscience | $750.52 | 2020-2022 | |
| Arthrex, INC. | $575.30 | 2019-2024 | |
| Mission Medical Distribution, LLC | $471.33 | 2023-2025 | |
| Medinc of Texas | $432.80 | 2020 | |
| Smith+Nephew, INC. | $356.70 | 2019-2024 | Bone Anchors With Arthroscopic Delivery System, Pico |
| Acumed LLC | $347.75 | 2022-2025 | Acumed, Acumed |
| Kowa Pharmaceuticals America, INC. | $207.35 | 2022-2023 | Seglentis |
| Exactech, INC. | $198.35 | 2019 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $169.07 | 2019-2020 | |
| Lima USA, INC. | $95.97 | 2019 | |
| Medtronic, INC. | $86.21 | 2022-2024 | Signia, Ligasure |
| Trevena, INC. | $84.56 | 2021 | |
| Si-Bone, INC. | $69.81 | 2022-2023 | |
| Anika Therapeutics, INC. | $57.93 | 2023-2024 | Tactoset, Glenojet, Ovomotion |
| Davol INC. | $53.15 | 2022-2025 | Surgiphor |
| Abbott Laboratories | $51.29 | 2019-2021 | |
| Fidia Pharma USA INC. | $41.02 | 2020-2023 | Hymovis |
| Convatec INC. | $38.45 | 2019-2020 | |
| Fx Shoulder Solutions, INC | $34.44 | 2025 | |
| Djo, LLC | $33.54 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $30.37 | 2019-2025 | Exparel |
| Integra Lifesciences Corporation | $28.66 | 2022 | |
| Avanos Medical | $22.16 | 2021 | |
| Vericel Corporation | $21.65 | 2023 | Maci |
| Theragen, INC. | $16.66 | 2022 | |
| Arthrosurface Incorporated | $16.11 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.97 | 2019 | |
| Kci USA, INC. | $14.91 | 2021 | |
| Heron Therapeutics, INC. | $10.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adham Abdelfattah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.